Substantial equivalence: Its uses and abuses

From

View current issue Submit your manuscript

This is a preview of subscription content, log in via an institution to check access.

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Losey, J.E., et al. Nature 399, 214 (1999).
Article CAS Google Scholar
Masood, E. Nature 398, 98 (1999).
PubMed Google Scholar
Millstone, E., et al. Nature 401, 525–526 (1999).
Article CAS Google Scholar
Anon. Recombinant DNA Safety Considerations. Paris: OECD, 1986.
Anon. Nature 356, 1– 2 (1992).
Field Testing Genetically Modified Organisms: Framework for Decisions. Washington DC: National Academy Press, 1989.
Anon. Safety Evaluation of Foods Derived by Modern Biotechnology, Paris: OECD, 1993.
Anon. Report of the OECD Workshop on the Toxicological and Nutritional Testing of Novel Foods. SG/ICGB(98) 1, September 1998. Paris: OECD, 1998.
Anon. US Food and Drug Administration. Statement of Policy: Foods Derived from New Plant Varieties: Federal Register 57, 22984–23005 (1992).
MacKenzie, D. New Scientist,17 April 1999.

Henry I.Miller: He was founding director of the US Food and Drug Administration's Office of Biotechnology, 1989-93 and a member of the OECD Group of Experts on Safety in Biotechnology, 1984-92.

senior research fellow at the Hoover Institution, Stanford University, Stanford, 94305-6010, CA
Henry I. Miller

Authors

Henry I. Miller
View author publications
You can also search for this author in PubMed Google Scholar

Miller, H. Substantial equivalence: Its uses and abuses. Nat Biotechnol 17, 1042–1043 (1999). https://doi.org/10.1038/14987

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.